In the BioHarmony Drug Report Database

"Preview" Icon

Verteporfin

Visudyne (verteporfin) is a small molecule pharmaceutical. Verteporfin was first approved as Visudyne on 2000-04-12. It is used to treat choroidal neovascularization in the USA. It has been approved in Europe to treat degenerative myopia and macular degeneration.

 

Trade Name

 

Visudyne
 

Common Name

 

verteporfin
 

ChEMBL ID

 

CHEMBL2218885
 

Indication

 

choroidal neovascularization, degenerative myopia, macular degeneration
 

Drug Class

 

Benzoporphyrin derivatives

Image (chem structure or protein)

Verteporfin structure rendering